AVEO Pharmaceuticals, Inc. (AVEO)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.33% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+0.33% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+0.33% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+0.33% vs
Rating Accuracy
100.0% (1 of 1*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.8%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+8.76%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+8.76%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+109.02%
About
CEO
Michael P. Bailey
Employees
19
Industry
Oncology Biopharmaceuticals
Sector
Healthcare
Headquarters
Boston
Exchange
NASDAQ
Website
http://www.aveooncology.comSummary Stats
Market Cap
521M
Revenue
94.3M
Net Income
-29M
EPS
-$0.84
Price-to-Earnings
-17.83
Price-to-Book
18.08
Debt-to-Equity
2.51
News
Analyst Ratings
Price targets projected by 4 analysts
High
$17.00
Average
$11.25
Low
$7.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Above by $0.09
-$0.09 +50.0%
-0.18
-0.3
Up 70%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--